WebAug 14, 2024 · Clinical investigations shall be in line with the clinical evaluation plan as referred to in Part A of Annex XIV. 2.5. All the appropriate technical and functional features of the device, in particular those involving safety and performance, and their expected clinical outcomes shall be appropriately addressed in the investigational design. Web2024/2160 amending Annex XIV to REACH Regulation as regards the substance group 4- (1,1,3,3-Tetramethylbutyl)phenol, ethoxylated Commission Implementing Regulation (EU) 2024/876. laying down rules for the application of REACH Regulation Commission Regulation (EU) 2024/2045.
Prince George
WebLIST OF ANNEXES. ANNEX I. GENERAL PROVISIONS FOR ASSESSING SUBSTANCES AND PREPARING CHEMICAL SAFETY REPORTS. ANNEX II. REQUIREMENTS FOR THE … WebJan 24, 2024 · Last week, the European Chemicals Agency (ECHA) announced seven additions to the Substances of Very High Concern (SVHC) Candidate List for Annex XIV of the EU REACH regulation. This update brings the Candidate List to 181 SVHCs, up from 174. The seven substances are: Chrysene (EC No. 205-923-4; CAS No. 218-01-9) sickbird honda
REACH, ANNEX V :: ReachOnline
WebEU REACH Annex XIV Authorisation List includes 54 substances . FEBRUARY 2024 – RELEVANT FOR: ELECTRICAL AND ELECTRONICS, HARDLINES, SOFTLINES, TOYS AND … WebAllocation of (group s of) substances to LAD slots aims at an even workload for all parties during ... • Draft 11th Recommendation of Priority Substances to be included in Annex XIV of the REACH Regulation (List of Substances Subject to Authorisation). ECHA (2024b): Lead. ECHA’s dissemination website on registered substances. Accessed on 2 WebThe REACH Regulation aims to: ensure a high level of protection of human health and the environment against harmful substances assess the safety of chemical substances in use in the EU promote innovation and competitiveness promote alternative (non-animal) methods for the assessment of the hazards of substances Law the phhacility